Bio-Techne

Bio-Techne (Nasdaq/NYSE: TECH) is a Life Sciences Tools & Services company operating within the Health Care sector of the US equity market.

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

The company reports trailing twelve-month revenue of $311.42M and net income of $51.05M.

Key metrics include a return on equity of 2.5%.

Use FINOTAUR to track TECH's price action, review fundamentals, and stay current with company news — all in one research dashboard.